AAN Aaron's | Target Lowered by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.56
+3.8% | $9.00 ➝ $8.00 | Hold ➝ Hold | |
ABCL AbCellera Biologics | Target Lowered by | KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.84
-5.0% | $8.00 ➝ $7.00 | Overweight ➝ Overweight | |
ACCD Accolade | Target Lowered by | Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.12
-4.3% | $17.00 ➝ $13.00 | Buy ➝ Buy | |
ACM AECOM | Reiterated by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $92.27
-0.9% | $106.00 ➝ $113.00 | Buy ➝ Buy | |
ADTN ADTRAN | Upgraded by | Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.47
+1.5% | $7.50 | Market Perform ➝ Outperform | |
ADTN ADTRAN | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.47
+1.5% | $8.00 | Buy ➝ Buy | |
|
AEVA Aeva Technologies | Target Lowered by | Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.46
+0.3% | $10.00 ➝ $7.00 | Buy ➝ Buy | |
AFRM Affirm | Reiterated by | JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.58
-9.5% | | Neutral | |
AGM Federal Agricultural Mortgage | Reiterated by | Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $179.01
+3.3% | $225.00 ➝ $212.00 | Outperform ➝ Outperform | |
ALAB Astera Labs | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $69.26
-9.1% | $85.00 | Buy ➝ Buy | |
ALHC Alignment Healthcare | Upgraded by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.78
-1.3% | $6.00 ➝ $8.00 | Neutral ➝ Overweight | |
AMBC Ambac Financial Group | Target Raised by | Compass Point
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.32
+1.6% | $18.00 ➝ $19.00 | Buy ➝ Buy | |
AMRK A-Mark Precious Metals | Downgraded by | Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.15
-5.4% | | Outperform ➝ Market Perform | |
ANET Arista Networks | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $291.67
+6.5% | $275.00 ➝ $285.00 | Neutral ➝ Neutral | |
ANET Arista Networks | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $291.67
+6.5% | $320.00 | Buy ➝ Buy | |
ANET Arista Networks | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $291.67
+6.5% | $268.00 ➝ $302.00 | Neutral ➝ Neutral | |
ANET Arista Networks | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $291.67
+6.5% | $310.00 ➝ $340.00 | Overweight ➝ Overweight | |
ANET Arista Networks | Target Raised by | KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $291.67
+6.5% | $306.00 ➝ $349.00 | Overweight ➝ Overweight | |
APEI American Public Education | Target Raised by | Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.87
+17.7% | $17.00 ➝ $20.00 | Outperform ➝ Outperform | |
APLM Apollomics | Target Lowered by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.41
+2.7% | $5.00 ➝ $2.00 | Buy ➝ Buy | |
APLS Apellis Pharmaceuticals | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.30
-3.6% | $92.00 | Buy ➝ Buy | |
APLS Apellis Pharmaceuticals | Target Lowered by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.30
-3.6% | $67.00 ➝ $60.00 | Buy ➝ Buy | |
APLS Apellis Pharmaceuticals | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.30
-3.6% | $89.00 ➝ $85.00 | Buy ➝ Buy | |
APLS Apellis Pharmaceuticals | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.30
-3.6% | $85.00 | Buy ➝ Buy | |
APTV Aptiv | Target Raised by | Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $83.20
+0.2% | $92.00 ➝ $94.00 | Buy ➝ Buy | |
ARMK Aramark | Target Raised by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.86
+3.6% | $35.00 ➝ $37.00 | Neutral ➝ Neutral | |
ARVN Arvinas | Target Lowered by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.37
-5.7% | $72.00 ➝ $68.00 | Buy ➝ Buy | |
ARVN Arvinas | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.37
-5.7% | $87.00 | Buy ➝ Buy | |
ARVN Arvinas | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.37
-5.7% | $57.00 | Outperform ➝ Outperform | |
ASTH Astrana Health | Target Lowered by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.09
+0.4% | $50.00 ➝ $45.00 | Buy ➝ Buy | |
ATEC Alphatec | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.60
-21.9% | $23.00 | Buy ➝ Buy | |
ATEC Alphatec | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.60
-21.9% | $19.00 ➝ $17.00 | Overweight ➝ Overweight | |
ATER Aterian | Upgraded by | Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.78
+9.4% | | Neutral ➝ Buy | |
ATKR Atkore | Target Lowered by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $157.63
+2.1% | $200.00 ➝ $188.00 | Neutral ➝ Neutral | |
ATSG Air Transport Services Group | Target Raised by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.59
-0.8% | $16.00 ➝ $18.00 | Buy ➝ Buy | |
ATSG Air Transport Services Group | Target Raised by | Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.59
-0.8% | $14.00 ➝ $15.00 | Neutral ➝ Neutral | |
AUDC AudioCodes | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.88
-0.4% | $12.00 ➝ $10.00 | Underweight ➝ Underweight | |
AVDL Avadel Pharmaceuticals | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.25
-10.6% | $22.00 | Buy ➝ Buy | |
AVNT Avient | Target Raised by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.12
-2.6% | $49.00 ➝ $53.00 | Buy ➝ Buy | |
AVNT Avient | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.12
-2.6% | $50.00 ➝ $52.00 | Overweight ➝ Overweight | |
“Crash Insurance” For Your Retirement (Ad) When it comes to retirement, everyone fears one thing…
Outliving their retirement savings.
You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio.
 Click here to register for free. |
AVY Avery Dennison | Target Raised by | Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $225.10
+0.5% | $240.00 ➝ $245.00 | Buy ➝ Buy | |
AXON Axon Enterprise | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $311.86
-0.3% | $308.00 ➝ $381.00 | Overweight ➝ Overweight | |
AXSM Axsome Therapeutics | Target Lowered by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.68
-1.6% | $109.00 ➝ $106.00 | Buy ➝ Buy | |
AZPN Aspen Technology | Target Lowered by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $197.79
+4.8% | $225.00 ➝ $210.00 | Outperform ➝ Outperform | |
AZPN Aspen Technology | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $197.79
+4.8% | $196.00 ➝ $180.00 | Neutral ➝ Neutral | |
BAND Bandwidth | Target Raised by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.15
-6.2% | $21.00 ➝ $25.00 | Neutral ➝ Neutral | |
BAND Bandwidth | Target Raised by | KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.15
-6.2% | $21.00 ➝ $32.00 | Overweight ➝ Overweight | |
BAND Bandwidth | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.15
-6.2% | $22.00 ➝ $28.00 | Overweight ➝ Overweight | |
BAND Bandwidth | Target Raised by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.15
-6.2% | $32.00 ➝ $36.00 | Market Outperform ➝ Market Outperform | |
BAND Bandwidth | Target Raised by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.15
-6.2% | $38.00 ➝ $40.00 | Buy ➝ Buy | |
BEAM Beam Therapeutics | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.24
-1.3% | $42.00 ➝ $33.00 | Equal Weight ➝ Equal Weight | |
BIO Bio-Rad Laboratories | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $268.26
-4.2% | $420.00 ➝ $385.00 | Buy ➝ Buy | |
BL BlackLine | Target Raised by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.51
-1.5% | $61.00 ➝ $72.00 | Outperform ➝ Outperform | |
BL BlackLine | Target Raised by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.51
-1.5% | $65.00 ➝ $67.00 | Market Perform ➝ Market Perform | |
BLD TopBuild | Target Raised by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $396.75
+0.0% | $450.00 ➝ $470.00 | Buy ➝ Buy | |
BLDP Ballard Power Systems | Target Lowered by | CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.88
+1.4% | $3.75 ➝ $3.50 | Neutral ➝ Neutral | |
BLDP Ballard Power Systems | Target Lowered by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.88
+1.4% | $3.50 ➝ $3.25 | Hold | |
BLDP Ballard Power Systems | Target Lowered by | National Bankshares
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.88
+1.4% | $4.50 ➝ $4.00 | Sector Perform | |
BLDP Ballard Power Systems | Target Raised by | TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.88
+1.4% | $2.50 ➝ $2.75 | Hold | |
BLDP Ballard Power Systems | Target Lowered by | HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.88
+1.4% | $4.10 ➝ $3.80 | Buy ➝ Buy | |
BLDP Ballard Power Systems | Reiterated by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.88
+1.4% | $3.50 ➝ $3.00 | Hold ➝ Hold | |
BLDR Builders FirstSource | Target Lowered by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $163.46
+0.5% | $190.00 ➝ $180.00 | Hold ➝ Hold | |
BLDR Builders FirstSource | Target Lowered by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $163.46
+0.5% | $207.00 ➝ $197.00 | Neutral ➝ Neutral | |
BLDR Builders FirstSource | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $163.46
+0.5% | $240.00 ➝ $200.00 | Overweight ➝ Overweight | |
BLMN Bloomin' Brands | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.89
-0.3% | $32.00 ➝ $30.00 | Overweight ➝ Overweight | |
BLMN Bloomin' Brands | Target Lowered by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.89
-0.3% | $29.00 ➝ $27.00 | Market Perform ➝ Market Perform | |
BLMN Bloomin' Brands | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.89
-0.3% | $30.00 ➝ $26.00 | Neutral ➝ Neutral | |
BNTX BioNTech | Target Raised by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $90.13
-0.8% | $107.00 ➝ $113.00 | Buy ➝ Buy | |
BP BP | Target Raised by | TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.53
-0.1% | $43.00 ➝ $44.00 | Buy | |
BRBR BellRing Brands | Target Raised by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.08
-0.6% | $64.00 ➝ $70.00 | Buy ➝ Buy | |
BRBR BellRing Brands | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.08
-0.6% | $60.00 ➝ $65.00 | Outperform ➝ Outperform | |
BRBR BellRing Brands | Target Raised by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.08
-0.6% | $60.00 ➝ $68.00 | Buy ➝ Buy | |
BRBR BellRing Brands | Target Raised by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.08
-0.6% | $63.00 ➝ $67.00 | Buy ➝ Buy | |
BROS Dutch Bros | Target Raised by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.77
+11.8% | $37.00 ➝ $39.00 | Outperform ➝ Outperform | |
BROS Dutch Bros | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.77
+11.8% | $30.00 ➝ $35.00 | Equal Weight ➝ Equal Weight | |
BSY Bentley Systems | Target Raised by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.36
-1.0% | $57.00 ➝ $60.00 | Buy ➝ Buy | |
BSY Bentley Systems | Reiterated by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.36
-1.0% | $60.00 ➝ $63.00 | Overweight ➝ Overweight | |
BVS Bioventus | Target Raised by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.04
-1.6% | $7.00 ➝ $8.00 | Buy ➝ Buy | |
BWMN Bowman Consulting Group | Target Lowered by | Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.08
-3.5% | $49.00 ➝ $47.00 | Buy ➝ Buy | |
BYON Beyond | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.33
-1.2% | $26.00 ➝ $17.00 | Neutral ➝ Neutral | |
BYON Beyond | Target Lowered by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.33
-1.2% | $43.00 ➝ $37.00 | Outperform ➝ Outperform | |
BYON Beyond | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.33
-1.2% | $30.00 ➝ $22.00 | Equal Weight ➝ Equal Weight | |
BYON Beyond | Downgraded by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.33
-1.2% | | Buy ➝ Hold | |
BYON Beyond | Target Lowered by | Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.33
-1.2% | $50.00 ➝ $36.00 | Buy ➝ Buy | |
CELH Celsius | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.13
+0.2% | $99.00 ➝ $92.00 | Buy ➝ Buy | |
CFLT Confluent | Reiterated by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38
+12.8% | $33.00 ➝ $36.00 | Buy ➝ Buy | |
CFLT Confluent | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38
+12.8% | $38.00 | Buy ➝ Buy | |
CFLT Confluent | Upgraded by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38
+12.8% | $35.00 | Hold ➝ Buy | |
CFLT Confluent | Upgraded by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38
+12.8% | $28.00 ➝ $35.00 | Hold ➝ Buy | |
CFLT Confluent | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38
+12.8% | $33.00 ➝ $34.00 | Overweight ➝ Overweight | |
“Crash Insurance” For Your Retirement (Ad) When it comes to retirement, everyone fears one thing…
Outliving their retirement savings.
You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio.
Click here to register for free. |
CFLT Confluent | Target Raised by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38
+12.8% | $38.00 ➝ $40.00 | Market Outperform ➝ Market Outperform | |
CFLT Confluent | Target Raised by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38
+12.8% | $37.00 ➝ $40.00 | Outperform ➝ Outperform | |
CFLT Confluent | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38
+12.8% | $36.00 ➝ $38.00 | Overweight ➝ Overweight | |
CFLT Confluent | Target Raised by | Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38
+12.8% | $35.00 ➝ $37.00 | Buy ➝ Buy | |
CFLT Confluent | Target Raised by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.38
+12.8% | $34.00 ➝ $37.00 | Buy ➝ Buy | |
CIFR Cipher Mining | Reiterated by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.78
-0.3% | $5.50 ➝ $6.00 | Buy ➝ Buy | |
CIFR Cipher Mining | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.78
-0.3% | $5.00 | Buy ➝ Buy | |
CLNN Clene | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.39
-0.4% | $7.00 | Buy ➝ Buy | |
CMTG Claros Mortgage Trust | Target Lowered by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.22
-5.1% | $11.00 ➝ $9.00 | Equal Weight ➝ Equal Weight | |
COGT Cogent Biosciences | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.60
-2.1% | $18.00 | Buy ➝ Buy | |
CPNG Coupang | Target Raised by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.46
-9.3% | $20.00 ➝ $23.00 | Neutral ➝ Neutral | |
CPNG Coupang | Target Raised by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.46
-9.3% | $26.00 ➝ $28.00 | Buy ➝ Buy | |
CRBP Corbus Pharmaceuticals | Target Raised by | Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.39
+6.6% | $58.00 ➝ $60.00 | Outperform ➝ Outperform | |
CRIS Curis | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.35
+0.9% | $26.00 | Buy ➝ Buy | |
CROX Crocs | Target Raised by | Monness Crespi & Hardt
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $135.75
-0.5% | $140.00 ➝ $170.00 | Buy | |
CROX Crocs | Target Raised by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $135.75
-0.5% | $140.00 ➝ $158.00 | Buy ➝ Buy | |
CROX Crocs | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $135.75
-0.5% | $124.00 ➝ $148.00 | Neutral ➝ Neutral | |
CROX Crocs | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $135.75
-0.5% | $167.00 ➝ $169.00 | Overweight ➝ Overweight | |
CRS Carpenter Technology | Target Raised by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $103.55
+1.0% | $100.00 ➝ $140.00 | Buy ➝ Buy | |
CRSR Corsair Gaming | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.79
-8.2% | $18.00 | Outperform ➝ Outperform | |
CRUS Cirrus Logic | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $102.24
+12.2% | $95.00 ➝ $110.00 | Overweight ➝ Overweight | |
CRUS Cirrus Logic | Target Raised by | KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $102.24
+12.2% | $100.00 ➝ $120.00 | Overweight ➝ Overweight | |
CRUS Cirrus Logic | Target Raised by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $102.24
+12.2% | $100.00 ➝ $110.00 | Buy ➝ Buy | |
CRUS Cirrus Logic | Target Raised by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $102.24
+12.2% | $100.00 ➝ $115.00 | Buy ➝ Buy | |
CRUS Cirrus Logic | Target Raised by | Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $102.24
+12.2% | $100.00 ➝ $120.00 | Positive ➝ Positive | |
CTV Innovid | Target Raised by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.94
-12.6% | $2.25 ➝ $3.00 | Buy ➝ Buy | |
CURI CuriosityStream | Target Raised by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.15
-6.5% | $1.25 ➝ $1.35 | Buy ➝ Buy | |
CVS CVS Health | Target Lowered by | Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.91
-1.5% | $100.00 ➝ $80.00 | Buy ➝ Buy | |
CXDO Crexendo | Upgraded by | B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | J. Nichols
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $3.94
-15.3% | $6.75 ➝ $5.75 | Neutral ➝ Buy | |
CYRX Cryoport | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.20
-19.5% | $18.00 | Buy ➝ Buy | |
CYTK Cytokinetics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.27
0.0% | $94.00 | Buy ➝ Buy | |
DBVT DBV Technologies | Target Lowered by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.72
+5.1% | $10.00 ➝ $5.00 | Buy ➝ Buy | |
DDOG Datadog | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.28
+4.3% | $152.00 ➝ $145.00 | Overweight ➝ Overweight | |
DDOG Datadog | Target Lowered by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.28
+4.3% | $155.00 ➝ $140.00 | Outperform ➝ Outperform | |
DDOG Datadog | Upgraded by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $117.28
+4.3% | $130.00 ➝ $140.00 | Neutral ➝ Outperform | |
DH Definitive Healthcare | Downgraded by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.35
-26.2% | $11.50 ➝ $9.00 | Overweight ➝ Equal Weight | |
DH Definitive Healthcare | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.35
-26.2% | | Hold | |
DH Definitive Healthcare | Target Lowered by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.35
-26.2% | $11.00 ➝ $9.50 | Buy ➝ Buy | |
DH Definitive Healthcare | Target Lowered by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.35
-26.2% | $10.00 ➝ $8.00 | Hold ➝ Hold | |
DIS Walt Disney | Target Lowered by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.44
+0.0% | $130.00 ➝ $128.00 | Outperform ➝ Outperform | |
DIS Walt Disney | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.44
+0.0% | $135.00 ➝ $130.00 | Overweight ➝ Overweight | |
DIS Walt Disney | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $105.44
+0.0% | $140.00 ➝ $130.00 | Buy ➝ Buy | |
DK Delek US | Target Lowered by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.84
-0.3% | $27.00 ➝ $25.00 | Hold ➝ Hold | |
DNLI Denali Therapeutics | Target Lowered by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.90
+12.2% | $26.00 ➝ $22.00 | Hold ➝ Hold | |
DNLI Denali Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.90
+12.2% | $95.00 | Buy ➝ Buy | |
DNLI Denali Therapeutics | Target Lowered by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.90
+12.2% | $31.00 ➝ $30.00 | Outperform ➝ Outperform | |
DT Dynatrace | Target Lowered by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $46.07
-1.5% | $63.00 ➝ $55.00 | Outperform ➝ Outperform | |
DUK Duke Energy | Target Raised by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $102.38
+0.1% | $104.00 ➝ $108.00 | Outperform ➝ Outperform | |
DV DoubleVerify | Target Lowered by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.78
-38.6% | $48.00 ➝ $40.00 | Buy ➝ Buy | |
DV DoubleVerify | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.78
-38.6% | $40.00 ➝ $30.00 | Overweight ➝ Overweight | |
Tech GIANT’s Plans to Revolutionize Crypto… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
 Claim your free seat by clicking here now. |
DV DoubleVerify | Target Lowered by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.78
-38.6% | $40.00 ➝ $34.00 | Market Outperform ➝ Market Outperform | |
DV DoubleVerify | Target Lowered by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.78
-38.6% | $49.00 ➝ $40.00 | Outperform ➝ Outperform | |
DV DoubleVerify | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.78
-38.6% | $40.00 ➝ $30.00 | Overweight ➝ Overweight | |
DV DoubleVerify | Target Lowered by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.78
-38.6% | $39.00 ➝ $32.00 | Buy ➝ Buy | |
DV DoubleVerify | Target Lowered by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.78
-38.6% | $37.00 ➝ $25.00 | Buy ➝ Buy | |
DV DoubleVerify | Downgraded by | KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.78
-38.6% | | Overweight ➝ Sector Weight | |
DV DoubleVerify | Target Lowered by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.78
-38.6% | $45.00 ➝ $33.00 | Buy ➝ Buy | |
DV DoubleVerify | Target Lowered by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.78
-38.6% | $42.00 ➝ $34.00 | Outperform ➝ Outperform | |
EA Electronic Arts | Target Lowered by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $125.24
-3.8% | $160.00 ➝ $150.00 | Outperform ➝ Outperform | |
EA Electronic Arts | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $125.24
-3.8% | $162.00 | Outperform ➝ Outperform | |
ENR Energizer | Target Lowered by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.29
+1.1% | $33.00 ➝ $32.00 | Hold ➝ Hold | |
ENR Energizer | Upgraded by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.29
+1.1% | $33.00 | Underweight ➝ Equal Weight | |
ENR Energizer | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.29
+1.1% | $30.00 ➝ $31.00 | Neutral ➝ Neutral | |
ENR Energizer | Target Lowered by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.29
+1.1% | $35.00 ➝ $30.00 | Hold ➝ Hold | |
ENV Envestnet | Upgraded by | Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.76
+1.6% | $47.00 ➝ $59.00 | Underperform ➝ Hold | |
ENV Envestnet | Target Raised by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.76
+1.6% | $56.00 ➝ $64.00 | Sector Perform ➝ Sector Perform | |
EOLS Evolus | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.26
-1.2% | $27.00 | Buy ➝ Buy | |
EOLS Evolus | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.26
-1.2% | $22.00 | Buy ➝ Buy | |
ESPR Esperion Therapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.04
-13.9% | $16.00 | Buy ➝ Buy | |
EVGO EVgo | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.75
-2.2% | | Hold | |
EXLS ExlService | Upgraded by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.81
+0.4% | $34.00 ➝ $40.00 | Neutral ➝ Outperform | |
EXPD Expeditors International of Washington | Target Raised by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $116.83
+1.7% | $111.00 ➝ $112.00 | Hold | |
EXPD Expeditors International of Washington | Target Raised by | Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $116.83
+1.7% | $112.00 ➝ $120.00 | Neutral ➝ Neutral | |
EYPT EyePoint Pharmaceuticals | Target Lowered by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.56
-2.6% | $46.00 ➝ $38.00 | Outperform ➝ Outperform | |
FIS Fidelity National Information Services | Target Raised by | Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.05
-0.3% | $81.00 ➝ $86.00 | Positive ➝ Positive | |
FIS Fidelity National Information Services | Target Raised by | Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.05
-0.3% | $82.00 ➝ $85.00 | Outperform ➝ Outperform | |
FIS Fidelity National Information Services | Target Raised by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.05
-0.3% | $70.00 ➝ $75.00 | Hold ➝ Hold | |
FIS Fidelity National Information Services | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $74.05
-0.3% | $75.00 | Outperform ➝ Outperform | |
FLYW Flywire | Target Lowered by | BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.24
-16.1% | $34.00 ➝ $27.00 | Buy ➝ Buy | |
FLYW Flywire | Target Lowered by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.24
-16.1% | $41.00 ➝ $34.00 | Outperform ➝ Outperform | |
FLYW Flywire | Target Lowered by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.24
-16.1% | $36.00 ➝ $33.00 | Buy ➝ Buy | |
FLYW Flywire | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.24
-16.1% | $34.00 ➝ $26.00 | Buy ➝ Buy | |
FLYW Flywire | Reiterated by | William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.24
-16.1% | | Outperform | |
FMC FMC | Target Raised by | KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $64.84
-2.9% | $79.00 ➝ $81.00 | Overweight ➝ Overweight | |
FMC FMC | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $64.84
-2.9% | $65.00 ➝ $68.00 | Equal Weight ➝ Equal Weight | |
FRSH Freshworks | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.82
-3.1% | $30.00 | Buy ➝ Buy | |
FWRG First Watch Restaurant Group | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.85
+1.6% | $29.00 ➝ $27.00 | Overweight ➝ Overweight | |
FWRG First Watch Restaurant Group | Target Lowered by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.85
+1.6% | $26.00 ➝ $25.00 | Hold ➝ Hold | |
GBDC Golub Capital BDC | Downgraded by | Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.60
-1.4% | | Outperform ➝ Market Perform | |
GEO The GEO Group | Target Lowered by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.60
-0.2% | $22.00 ➝ $20.00 | Outperform ➝ Outperform | |
GFS GLOBALFOUNDRIES | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.36
-1.7% | | Hold | |
GFS GLOBALFOUNDRIES | Target Raised by | Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.36
-1.7% | $48.00 ➝ $50.00 | Neutral ➝ Neutral | |
GFS GLOBALFOUNDRIES | Target Raised by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.36
-1.7% | $62.00 ➝ $63.00 | Overweight ➝ Overweight | |
GMED Globus Medical | Target Raised by | BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $61.73
+20.2% | $60.00 ➝ $63.00 | Buy ➝ Buy | |
GMED Globus Medical | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $61.73
+20.2% | $55.00 ➝ $60.00 | Neutral ➝ Neutral | |
GMED Globus Medical | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $61.73
+20.2% | | Hold | |
GMED Globus Medical | Target Raised by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $61.73
+20.2% | $64.00 ➝ $70.00 | Buy ➝ Buy | |
GO Grocery Outlet | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.88
-19.4% | $30.00 ➝ $27.00 | Neutral ➝ Neutral | |
GO Grocery Outlet | Target Lowered by | Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.88
-19.4% | $37.00 ➝ $31.00 | Outperform | |
GOLF Acushnet | Target Raised by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.03
-3.7% | $62.00 ➝ $63.00 | Hold ➝ Hold | |
“Crash Insurance” For Your Retirement (Ad) When it comes to retirement, everyone fears one thing…
Outliving their retirement savings.
You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio.
Click here to register for free. |
GOSS Gossamer Bio | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.76
+3.3% | $4.00 | Outperform ➝ Outperform | |
GPRO GoPro | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Reese
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.71
-7.3% | $2.00 | Neutral ➝ Neutral | |
GT Goodyear Tire & Rubber | Target Lowered by | HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.67
+2.0% | $16.80 ➝ $15.90 | Buy ➝ Buy | |
GTLS Chart Industries | Initiated by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $156.90
-2.3% | $193.00 | Equal Weight ➝ Equal Weight | |
GTN Gray Television | Target Raised by | Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.74
+0.6% | $11.00 ➝ $13.00 | Buy ➝ Buy | |
GTN Gray Television | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.74
+0.6% | $5.50 ➝ $6.00 | Underweight ➝ Underweight | |
GWH ESS Tech | Target Lowered by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.78
-15.0% | $2.50 ➝ $2.00 | Buy ➝ Buy | |
HALO Halozyme Therapeutics | Target Lowered by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.01
+1.9% | $72.00 ➝ $71.00 | Market Outperform ➝ Market Outperform | |
HCKT The Hackett Group | Target Lowered by | Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.56
-2.9% | $28.00 ➝ $26.00 | Outperform ➝ Outperform | |
HLMN Hillman Solutions | Target Raised by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.59
+0.1% | $10.00 ➝ $11.00 | Outperform ➝ Outperform | |
HR Healthcare Realty Trust | Target Raised by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | R. Anderson
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $15.31
-0.6% | $15.00 ➝ $16.00 | Neutral ➝ Neutral | |
HRT HireRight | Upgraded by | William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Nicholas
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $14.33
-0.2% | | Market Perform ➝ Outperform | |
HRTX Heron Therapeutics | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.01
+4.9% | $5.00 | Buy ➝ Buy | |
HSIC Henry Schein | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $72.76
+2.2% | $82.00 ➝ $80.00 | Neutral ➝ Neutral | |
HSIC Henry Schein | Target Raised by | Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $72.76
+2.2% | $90.00 ➝ $92.00 | Outperform ➝ Outperform | |
HXL Hexcel | Upgraded by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $72.65
+2.1% | $81.00 ➝ $95.00 | Equal Weight ➝ Overweight | |
ICHR Ichor | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.86
-2.8% | $42.00 | Hold | |
ICHR Ichor | Target Raised by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.86
-2.8% | $42.00 ➝ $48.00 | Buy ➝ Buy | |
ICHR Ichor | Target Lowered by | Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.86
-2.8% | $55.00 ➝ $50.00 | Buy ➝ Buy | |
IDYA IDEAYA Biosciences | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.41
-3.1% | $52.00 | Outperform ➝ Outperform | |
IFF International Flavors & Fragrances | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.23
+3.1% | $100.00 ➝ $110.00 | Overweight ➝ Overweight | |
IFF International Flavors & Fragrances | Target Raised by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.23
+3.1% | $100.00 ➝ $108.00 | Buy ➝ Buy | |
IFF International Flavors & Fragrances | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.23
+3.1% | $82.00 ➝ $93.00 | Equal Weight ➝ Equal Weight | |
IFF International Flavors & Fragrances | Upgraded by | JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.23
+3.1% | $75.00 ➝ $100.00 | Neutral ➝ Overweight | |
IFF International Flavors & Fragrances | Target Raised by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $97.23
+3.1% | $100.00 ➝ $110.00 | Outperform ➝ Outperform | |
IMRX Immuneering | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.63
+4.5% | $15.00 | Buy ➝ Buy | |
INGN Inogen | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.24
+12.9% | | Hold | |
INGN Inogen | Target Raised by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $8.24
+12.9% | $6.00 ➝ $7.00 | Hold ➝ Hold | |
INSP Inspire Medical Systems | Downgraded by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $163.41
-33.5% | $265.00 ➝ $225.00 | Buy ➝ Neutral | |
INSP Inspire Medical Systems | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $163.41
-33.5% | $250.00 ➝ $255.00 | Overweight ➝ Overweight | |
INTA Intapp | Target Lowered by | BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $36.15
+9.0% | $55.00 ➝ $50.00 | Buy ➝ Buy | |
INZY Inozyme Pharma | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.64
+0.9% | $23.00 | Buy ➝ Buy | |
IONS Ionis Pharmaceuticals | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.16
-1.9% | $60.00 | Buy ➝ Buy | |
IONS Ionis Pharmaceuticals | Target Lowered by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $40.16
-1.9% | $85.00 ➝ $82.00 | Overweight ➝ Overweight | |
ITT ITT | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $136.39
+1.3% | $135.00 ➝ $158.00 | Buy ➝ Buy | |
J Jacobs Solutions | Target Lowered by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $138.51
-2.2% | $154.00 ➝ $153.00 | Hold ➝ Hold | |
J Jacobs Solutions | Downgraded by | William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $138.51
-2.2% | | Outperform ➝ Market Perform | |
J Jacobs Solutions | Target Lowered by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $138.51
-2.2% | $168.00 ➝ $163.00 | Outperform ➝ Outperform | |
JACK Jack in the Box | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.23
+0.6% | $81.00 ➝ $67.00 | Neutral ➝ Neutral | |
JANX Janux Therapeutics | Target Raised by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $55.37
-10.0% | $53.00 ➝ $74.00 | Outperform ➝ Outperform | |
JELD JELD-WEN | Target Lowered by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.97
-2.6% | $16.00 ➝ $13.00 | Underperform ➝ Underperform | |
JELD JELD-WEN | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.97
-2.6% | $22.00 ➝ $19.00 | Buy ➝ Buy | |
JKHY Jack Henry & Associates | Reiterated by | William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $165.59
0.0% | | Outperform | |
JLL Jones Lang LaSalle | Target Raised by | Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $191.09
+0.4% | $190.00 ➝ $200.00 | Market Perform ➝ Market Perform | |
KIDS OrthoPediatrics | Target Raised by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.18
-4.4% | $35.00 ➝ $38.00 | Hold ➝ Hold | |
KLG WK Kellogg | Downgraded by | BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.97
-9.5% | $20.00 | Neutral ➝ Underperform | |
KLG WK Kellogg | Target Raised by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.97
-9.5% | $20.00 ➝ $22.00 | Hold ➝ Hold | |
KLG WK Kellogg | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.97
-9.5% | $21.00 ➝ $23.00 | In-Line ➝ In-Line | |
KLG WK Kellogg | Target Raised by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.97
-9.5% | $13.00 ➝ $24.00 | Hold ➝ Hold | |
KVUE Kenvue | Target Raised by | HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.45
+1.8% | $20.00 ➝ $21.00 | Hold ➝ Hold | |
LCID Lucid Group | Target Lowered by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.71
+3.4% | $4.00 ➝ $3.00 | Hold ➝ Hold | |
LGND Ligand Pharmaceuticals | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $80.26
+9.6% | $144.00 | Buy ➝ Buy | |
LOPE Grand Canyon Education | Target Raised by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.08
+5.2% | $165.00 ➝ $170.00 | Outperform ➝ Outperform | |
LOPE Grand Canyon Education | Target Raised by | Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.08
+5.2% | $160.00 ➝ $165.00 | Outperform ➝ Outperform | |
LOPE Grand Canyon Education | Target Raised by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.08
+5.2% | $150.00 ➝ $155.00 | Outperform ➝ Outperform | |
LPRO Open Lending | Target Lowered by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.57
+5.3% | $7.00 ➝ $6.00 | Hold ➝ Hold | |
LPRO Open Lending | Target Lowered by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.57
+5.3% | $8.00 ➝ $7.00 | Buy ➝ Buy | |
LULU Lululemon Athletica | Initiated by | BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $345.61
-1.2% | $425.00 | Buy | |
LYFT Lyft | Target Raised by | DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78
+7.1% | $15.00 ➝ $18.00 | Neutral ➝ Neutral | |
LYFT Lyft | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78
+7.1% | | Hold | |
LYFT Lyft | Target Raised by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78
+7.1% | $15.00 ➝ $18.00 | Hold ➝ Hold | |
LYFT Lyft | Target Raised by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78
+7.1% | $15.00 ➝ $18.00 | Market Perform ➝ Market Perform | |
LYFT Lyft | Target Raised by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78
+7.1% | $15.00 ➝ $18.00 | Neutral ➝ Neutral | |
LYFT Lyft | Target Raised by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78
+7.1% | $14.00 ➝ $16.00 | Hold ➝ Hold | |
LYFT Lyft | Target Raised by | Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78
+7.1% | $15.00 ➝ $19.00 | Market Perform ➝ Market Perform | |
LYFT Lyft | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78
+7.1% | $22.00 ➝ $23.00 | Overweight ➝ Overweight | |
LYFT Lyft | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78
+7.1% | $17.00 ➝ $20.00 | Equal Weight ➝ Equal Weight | |
LYFT Lyft | Target Raised by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78
+7.1% | $23.00 ➝ $24.00 | Outperform ➝ Outperform | |
LYFT Lyft | Target Raised by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.78
+7.1% | $15.00 ➝ $18.00 | Neutral ➝ Neutral | |
MARA Marathon Digital | Target Lowered by | Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.09
-0.6% | $30.00 ➝ $21.00 | Neutral ➝ Neutral | |
MASI Masimo | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.02
-11.8% | | Hold | |
MASI Masimo | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $120.02
-11.8% | $117.00 ➝ $126.00 | Neutral ➝ Neutral | |
MBWM Mercantile Bank | Downgraded by | Janney Montgomery Scott
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.56
+0.2% | | Buy ➝ Neutral | |
MCK McKesson | Target Raised by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $543.61
-0.4% | $603.00 ➝ $671.00 | Outperform ➝ Outperform | |
MCK McKesson | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $543.61
-0.4% | $620.00 ➝ $630.00 | Buy ➝ Buy | |
MCK McKesson | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $543.61
-0.4% | $571.00 ➝ $596.00 | Overweight ➝ Overweight | |
MCK McKesson | Target Raised by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $543.61
-0.4% | $563.00 ➝ $652.00 | Buy ➝ Buy | |
MCK McKesson | Target Raised by | Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $543.61
-0.4% | $590.00 ➝ $600.00 | Outperform ➝ Outperform | |
MDGL Madrigal Pharmaceuticals | Target Lowered by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $208.04
-4.6% | $425.00 ➝ $390.00 | Buy ➝ Buy | |
MDGL Madrigal Pharmaceuticals | Target Lowered by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $208.04
-4.6% | $397.00 ➝ $381.00 | Market Outperform ➝ Market Outperform | |
MDGL Madrigal Pharmaceuticals | Target Lowered by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $208.04
-4.6% | $389.00 ➝ $382.00 | Buy ➝ Buy | |
MKTX MarketAxess | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $202.21
+0.7% | $236.00 ➝ $225.00 | Equal Weight ➝ Equal Weight | |
MKTX MarketAxess | Target Lowered by | Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $202.21
+0.7% | $235.00 ➝ $230.00 | Market Perform ➝ Market Perform | |
MKTX MarketAxess | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $202.21
+0.7% | $305.00 ➝ $285.00 | Buy ➝ Buy | |
ML MoneyLion | Target Raised by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.64
+8.5% | $90.00 ➝ $100.00 | Buy ➝ Buy | |
ML MoneyLion | Target Raised by | Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $77.64
+8.5% | $100.00 ➝ $105.00 | Buy ➝ Buy | |
MLTX MoonLake Immunotherapeutics | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.63
-2.4% | $100.00 | Buy ➝ Buy | |
MLTX MoonLake Immunotherapeutics | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $42.63
-2.4% | $66.00 | Buy ➝ Buy | |
MQ Marqeta | Reiterated by | William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.84
+0.2% | | Outperform | |
MQ Marqeta | Target Raised by | Monness Crespi & Hardt
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.84
+0.2% | $7.50 ➝ $8.00 | Buy | |
MQ Marqeta | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.84
+0.2% | $6.00 | Neutral ➝ Neutral | |
MRCY Mercury Systems | Target Lowered by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $28.77
-1.2% | $28.00 ➝ $26.00 | Hold ➝ Hold | |
MTH Meritage Homes | Target Raised by | Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $180.72
+0.1% | $180.00 ➝ $195.00 | Market Perform ➝ Market Perform | |
MVBF MVB Financial | Target Lowered by | Hovde Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.37
-1.4% | $27.00 ➝ $23.00 | Outperform | |
MWA Mueller Water Products | Target Raised by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.92
+5.1% | $18.00 ➝ $24.00 | Neutral ➝ Neutral | |
MWA Mueller Water Products | Target Raised by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.92
+5.1% | $17.00 ➝ $20.00 | Sector Perform ➝ Sector Perform | |
MYGN Myriad Genetics | Upgraded by | SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.95
+21.1% | $25.00 ➝ $35.00 | Market Perform ➝ Outperform | |
NDAQ Nasdaq | Downgraded by | Rosenblatt Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.91
-1.6% | $76.00 ➝ $64.00 | Buy ➝ Neutral | |
NGVT Ingevity | Target Raised by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $54.00
+0.5% | $50.00 ➝ $55.00 | Market Perform ➝ Market Perform | |
NRBO NeuroBo Pharmaceuticals | Initiated by | Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.93
+2.3% | $10.00 | Buy | |
NRDY Nerdy | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.42
-8.7% | $4.00 | Buy ➝ Buy | |
NRG NRG Energy | Target Raised by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.82
+3.3% | $73.00 ➝ $82.00 | Market Perform ➝ Market Perform | |
NRG NRG Energy | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.82
+3.3% | $85.00 ➝ $100.00 | Overweight ➝ Overweight | |
NTNX Nutanix | Upgraded by | Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $66.21
+1.4% | $72.00 | Market Perform ➝ Outperform | |
NVCT Nuvectis Pharma | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.43
-10.6% | $21.00 | Buy ➝ Buy | |
NVEI Nuvei | Downgraded by | JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.48
+0.4% | $32.00 ➝ $34.00 | Overweight ➝ Neutral | |
NVRO Nevro | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.16
-11.9% | $15.00 ➝ $12.00 | Underweight ➝ Underweight | |
NVRO Nevro | Target Lowered by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.16
-11.9% | $14.00 ➝ $13.00 | Equal Weight ➝ Equal Weight | |
NVRO Nevro | Target Lowered by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.16
-11.9% | $17.00 ➝ $11.00 | Hold ➝ Hold | |
NYMT New York Mortgage Trust | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.02
-2.1% | $7.50 ➝ $6.00 | Neutral ➝ Neutral | |
OCN Ocwen Financial | Target Raised by | Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.05
-0.4% | $28.00 ➝ $32.00 | Market Perform ➝ Market Perform | |
OCUL Ocular Therapeutix | Target Lowered by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.75
-3.0% | $11.00 ➝ $7.00 | Hold ➝ Hold | |
OCUL Ocular Therapeutix | Target Lowered by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.75
-3.0% | $16.00 ➝ $14.00 | Buy ➝ Buy | |
OCUL Ocular Therapeutix | Target Lowered by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.75
-3.0% | $24.00 ➝ $22.00 | Market Outperform ➝ Market Outperform | |
ODFL Old Dominion Freight Line | Upgraded by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $181.70
-1.7% | $205.00 | Neutral ➝ Outperform | |
OFIX Orthofix Medical | Upgraded by | Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.90
+7.3% | $15.00 ➝ $20.00 | Neutral ➝ Buy | |
ONTF ON24 | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.46
-4.4% | | Hold | |
OPAD Offerpad Solutions | Target Lowered by | Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.86
+1.8% | $6.25 ➝ $6.00 | Underperform ➝ Underperform | |
OPK OPKO Health | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.25
-3.8% | $3.00 | Buy ➝ Buy | |
OXY Occidental Petroleum | Target Raised by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.68
-2.1% | $70.00 ➝ $71.00 | Neutral ➝ Neutral | |
PAA Plains All American Pipeline | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.66
+1.0% | $19.00 ➝ $20.00 | Overweight ➝ Overweight | |
PAGP Plains GP | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.52
+1.4% | $19.00 ➝ $20.00 | Overweight ➝ Overweight | |
PARR Par Pacific | Target Lowered by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.07
-2.4% | $45.00 ➝ $42.00 | Buy ➝ Buy | |
PAYS Paysign | Target Raised by | Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.57
-2.1% | $5.50 ➝ $6.00 | Buy ➝ Buy | |
PCRX Pacira BioSciences | Target Lowered by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.65
+11.8% | $45.00 ➝ $43.00 | Buy ➝ Buy | |
PCRX Pacira BioSciences | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.65
+11.8% | $57.00 | Buy ➝ Buy | |
PCRX Pacira BioSciences | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $29.65
+11.8% | $40.00 ➝ $38.00 | Overweight ➝ Overweight | |
PEN Penumbra | Target Lowered by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $203.09
-3.3% | $284.00 ➝ $272.00 | Buy ➝ Buy | |
PEN Penumbra | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $203.09
-3.3% | $290.00 ➝ $260.00 | Overweight ➝ Overweight | |
PEN Penumbra | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $203.09
-3.3% | | Hold | |
PINC Premier | Downgraded by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.61
+1.0% | $27.00 ➝ $21.00 | Buy ➝ Hold | |
PINC Premier | Target Lowered by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.61
+1.0% | $25.00 ➝ $22.00 | Neutral ➝ Neutral | |
PINC Premier | Reiterated by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.61
+1.0% | $27.00 ➝ $21.00 | Buy ➝ Hold | |
PINC Premier | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.61
+1.0% | $24.00 ➝ $22.00 | Neutral ➝ Neutral | |
PLBY PLBY Group | Reiterated by | Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.04
+3.0% | $4.00 ➝ $4.00 | Buy ➝ Buy | |
PR Permian Resources | Target Raised by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.27
-1.6% | $20.00 ➝ $21.00 | Buy ➝ Buy | |
PRA ProAssurance | Target Raised by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.72
-2.9% | $14.00 ➝ $16.00 | Hold ➝ Hold | |
PRO PROS | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.56
-7.3% | $40.00 | Buy ➝ Buy | |
PRPL Purple Innovation | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.53
-8.9% | $2.25 | Outperform ➝ Outperform | |
PRTS CarParts.com | Reiterated by | Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.13
-2.6% | $4.00 ➝ $2.00 | Buy ➝ Hold | |
PTGX Protagonist Therapeutics | Target Raised by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.11
+5.1% | $42.00 ➝ $45.00 | Market Outperform ➝ Market Outperform | |
PTLO Portillo's | Target Lowered by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.35
-2.5% | $17.00 ➝ $15.00 | Outperform ➝ Outperform | |
PTLO Portillo's | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.35
-2.5% | $18.00 ➝ $13.00 | Neutral ➝ Neutral | |
PUBM PubMatic | Target Raised by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.58
-6.0% | $26.00 ➝ $30.00 | Outperform ➝ Outperform | |
PWSC PowerSchool | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.15
+15.1% | $28.00 ➝ $23.00 | Overweight ➝ Overweight | |
PWSC PowerSchool | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.15
+15.1% | $26.00 | Buy ➝ Buy | |
PWSC PowerSchool | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.15
+15.1% | $25.00 ➝ $20.00 | Neutral ➝ Neutral | |
QLYS Qualys | Target Lowered by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $149.75
-9.8% | $175.00 ➝ $165.00 | Hold ➝ Hold | |
QLYS Qualys | Target Lowered by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $149.75
-9.8% | $175.00 ➝ $170.00 | Neutral ➝ Neutral | |
QURE uniQure | Target Lowered by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.89
+1.5% | $7.00 ➝ $6.00 | Neutral ➝ Neutral | |
QURE uniQure | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.89
+1.5% | $25.00 | Buy ➝ Buy | |
RDDT Reddit | Target Raised by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 51.40
+4.0% | $53.00 ➝ $63.00 | Market Outperform ➝ Market Outperform | |
RDDT Reddit | Target Raised by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 51.40
+4.0% | $53.00 ➝ $65.00 | Buy ➝ Buy | |
RDDT Reddit | Target Raised by | Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 51.40
+4.0% | $40.00 ➝ $45.00 | Underperform ➝ Underperform | |
RDDT Reddit | Target Raised by | Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 51.40
+4.0% | $50.00 ➝ $61.00 | Buy ➝ Buy | |
RDDT Reddit | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 51.40
+4.0% | $50.00 ➝ $65.00 | Overweight ➝ Overweight | |
RDDT Reddit | Target Raised by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 51.40
+4.0% | $50.00 ➝ $59.00 | Neutral ➝ Neutral | |
RDDT Reddit | Target Raised by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | 51.40
+4.0% | $55.00 ➝ $63.00 | Buy ➝ Buy | |
RDFN Redfin | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.25
-1.9% | | Hold | |
RDFN Redfin | Upgraded by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.25
-1.9% | $8.00 ➝ $9.00 | Equal Weight ➝ Overweight | |
RDFN Redfin | Target Lowered by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $6.25
-1.9% | $8.00 ➝ $7.00 | Neutral ➝ Neutral | |
RDY Dr. Reddy's Laboratories | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $71.50
+0.2% | $80.00 ➝ $81.00 | Overweight ➝ Overweight | |
REAL RealReal | Target Raised by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.08
+7.9% | $3.00 ➝ $4.50 | Outperform ➝ Outperform | |
REAL RealReal | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.08
+7.9% | $6.00 | Buy ➝ Buy | |
REAL RealReal | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.08
+7.9% | $2.00 ➝ $4.00 | Equal Weight ➝ Equal Weight | |
RIGL Rigel Pharmaceuticals | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.99
-16.8% | $15.00 | Buy ➝ Buy | |
RIVN Rivian Automotive | Target Lowered by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.27
+0.2% | $12.00 ➝ $11.00 | Neutral ➝ Neutral | |
RIVN Rivian Automotive | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.27
+0.2% | $13.00 | Buy ➝ Buy | |
RIVN Rivian Automotive | Target Lowered by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.27
+0.2% | $14.00 ➝ $10.00 | Equal Weight ➝ Equal Weight | |
RIVN Rivian Automotive | Target Lowered by | Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.27
+0.2% | $23.00 ➝ $15.00 | Overweight ➝ Overweight | |
RNAC Cartesian Therapeutics | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.25
+0.2% | $42.00 | Buy ➝ Buy | |
RNG RingCentral | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.38
+14.6% | $31.00 ➝ $33.00 | Equal Weight ➝ Equal Weight | |
RNG RingCentral | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.38
+14.6% | $31.00 ➝ $32.00 | Neutral ➝ Neutral | |
RNG RingCentral | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.38
+14.6% | $37.00 ➝ $40.00 | Neutral ➝ Neutral | |
RNG RingCentral | Target Raised by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.38
+14.6% | $36.00 ➝ $38.00 | Buy ➝ Buy | |
RNG RingCentral | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.38
+14.6% | $42.00 | Buy ➝ Buy | |
ROK Rockwell Automation | Target Lowered by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $273.59
+0.6% | $310.00 ➝ $304.00 | Outperform ➝ Outperform | |
ROK Rockwell Automation | Target Lowered by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $273.59
+0.6% | $265.00 ➝ $260.00 | Neutral ➝ Neutral | |
ROK Rockwell Automation | Target Lowered by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $273.59
+0.6% | $320.00 ➝ $312.00 | Overweight ➝ Overweight | |
ROK Rockwell Automation | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $273.59
+0.6% | $265.00 ➝ $260.00 | Underweight ➝ Underweight | |
ROK Rockwell Automation | Target Lowered by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $273.59
+0.6% | $322.00 ➝ $316.00 | Buy ➝ Buy | |
RPD Rapid7 | Target Lowered by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00
-17.0% | $65.00 ➝ $52.00 | Buy ➝ Buy | |
RPD Rapid7 | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00
-17.0% | $60.00 ➝ $49.00 | Equal Weight ➝ Equal Weight | |
RPD Rapid7 | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00
-17.0% | $56.00 ➝ $45.00 | Neutral ➝ Neutral | |
RPD Rapid7 | Target Lowered by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00
-17.0% | $60.00 ➝ $52.00 | Hold ➝ Hold | |
RPD Rapid7 | Target Lowered by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00
-17.0% | $70.00 ➝ $57.00 | Outperform ➝ Outperform | |
RPD Rapid7 | Target Lowered by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00
-17.0% | $50.00 ➝ $45.00 | Hold ➝ Hold | |
RPD Rapid7 | Target Lowered by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00
-17.0% | $63.00 ➝ $51.00 | Buy ➝ Buy | |
RPD Rapid7 | Target Lowered by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00
-17.0% | $62.00 ➝ $47.00 | Neutral ➝ Neutral | |
RPD Rapid7 | Target Lowered by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00
-17.0% | $62.00 ➝ $56.00 | Outperform ➝ Outperform | |
RPD Rapid7 | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.00
-17.0% | $70.00 ➝ $65.00 | Buy ➝ Buy | |
RRR Red Rock Resorts | Target Lowered by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $50.22
-7.6% | $61.00 ➝ $59.00 | Hold ➝ Hold | |
RRR Red Rock Resorts | Target Lowered by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $50.22
-7.6% | $69.00 ➝ $66.00 | Buy ➝ Buy | |
RRR Red Rock Resorts | Target Lowered by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $50.22
-7.6% | $66.00 ➝ $63.00 | Overweight ➝ Overweight | |
RRR Red Rock Resorts | Target Lowered by | JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $50.22
-7.6% | $66.00 ➝ $65.00 | Market Outperform ➝ Market Outperform | |
RRR Red Rock Resorts | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $50.22
-7.6% | $64.00 ➝ $63.00 | Overweight ➝ Overweight | |
RRX Regal Rexnord | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $157.37
+0.1% | $203.00 ➝ $199.00 | Overweight ➝ Overweight | |
RRX Regal Rexnord | Target Raised by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $157.37
+0.1% | $205.00 ➝ $208.00 | Outperform ➝ Outperform | |
RVLV Revolve Group | Target Raised by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.68
+2.5% | $19.00 ➝ $23.00 | Neutral ➝ Neutral | |
RVLV Revolve Group | Target Raised by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.68
+2.5% | $23.00 ➝ $25.00 | Buy ➝ Buy | |
RVLV Revolve Group | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.68
+2.5% | $13.00 ➝ $15.00 | Underweight ➝ Underweight | |
RVLV Revolve Group | Target Raised by | Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.68
+2.5% | $21.00 ➝ $26.00 | Buy ➝ Buy | |
RVLV Revolve Group | Target Raised by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.68
+2.5% | $17.00 ➝ $19.00 | Neutral ➝ Neutral | |
RVLV Revolve Group | Target Raised by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $21.68
+2.5% | $13.00 ➝ $15.00 | Market Perform ➝ Market Perform | |
RWAY Runway Growth Finance | Target Lowered by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.32
-7.0% | $13.00 ➝ $12.00 | Equal Weight ➝ Equal Weight | |
RWAY Runway Growth Finance | Downgraded by | Compass Point
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.32
-7.0% | $12.75 | Buy ➝ Neutral | |
RYTM Rhythm Pharmaceuticals | Downgraded by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.92
-1.1% | $49.00 ➝ $42.00 | Buy ➝ Neutral | |
RYTM Rhythm Pharmaceuticals | Target Lowered by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $38.92
-1.1% | $80.00 ➝ $79.00 | Buy ➝ Buy | |
SAFE Safehold | Target Lowered by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.28
-2.6% | $32.00 ➝ $29.00 | Outperform ➝ Outperform | |
SAM Boston Beer | Upgraded by | Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $281.64
+3.1% | $273.00 | Sell ➝ Hold | |
SAR Saratoga Investment | Downgraded by | Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $22.88
-2.5% | $24.00 ➝ $23.00 | Outperform ➝ Market Perform | |
SAVE Spirit Airlines | Target Lowered by | Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating | C. Stathoulopoul
Subscribe to MarketBeat All Access for the recommendation accuracy rating | $3.40
+2.4% | $4.00 ➝ $3.00 | Negative ➝ Negative | |
SCOR comScore | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.30
-1.2% | $25.00 | Buy ➝ Buy | |
SCOR comScore | Target Lowered by | Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.30
-1.2% | $24.00 ➝ $18.00 | Buy ➝ Buy | |
SEAT Vivid Seats | Target Lowered by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.35
-1.1% | $12.00 ➝ $10.00 | Buy ➝ Buy | |
SEAT Vivid Seats | Target Raised by | Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.35
-1.1% | $7.00 ➝ $9.00 | Buy ➝ Buy | |
SEMR Semrush | Target Raised by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.38
+5.0% | $15.00 ➝ $18.00 | Buy ➝ Buy | |
SGRY Surgery Partners | Target Lowered by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.17
-2.2% | $42.00 ➝ $38.00 | Buy ➝ Buy | |
SHLS Shoals Technologies Group | Target Lowered by | Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.51
-14.7% | $24.00 ➝ $14.00 | Overweight ➝ Overweight | |
SHLS Shoals Technologies Group | Target Lowered by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.51
-14.7% | $14.00 ➝ $11.00 | Overweight ➝ Overweight | |
SHLS Shoals Technologies Group | Reiterated by | Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.51
-14.7% | $12.00 ➝ $6.00 | Market Perform ➝ Underperform | |
SHLS Shoals Technologies Group | Target Lowered by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.51
-14.7% | $16.00 ➝ $13.00 | Buy ➝ Buy | |
SHLS Shoals Technologies Group | Downgraded by | Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.51
-14.7% | $15.00 ➝ $8.00 | Buy ➝ Neutral | |
SHLS Shoals Technologies Group | Target Lowered by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.51
-14.7% | $15.00 ➝ $11.00 | Buy ➝ Buy | |
SKM SK Telecom | Upgraded by | Nomura
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.79
+0.3% | | Reduce ➝ Neutral | |
SKWD Skyward Specialty Insurance Group | Target Raised by | Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.16
-1.2% | $44.00 ➝ $46.00 | Outperform ➝ Outperform | |
SLDP Solid Power | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.74
-2.8% | $3.00 | Buy ➝ Buy | |
SNCY Sun Country Airlines | Target Lowered by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.34
-8.0% | $22.00 ➝ $17.00 | Buy | |
SPCE Virgin Galactic | Target Lowered by | Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.00
-1.5% | $2.00 ➝ $1.10 | Neutral ➝ Neutral | |
SPNS Sapiens International | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $33.52
+6.8% | $38.00 | Buy ➝ Buy | |
SPR Spirit AeroSystems | Target Raised by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.90
-6.1% | $33.00 ➝ $35.00 | Sector Perform ➝ Sector Perform | |
SPR Spirit AeroSystems | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.90
-6.1% | $35.00 ➝ $33.00 | Neutral ➝ Neutral | |
SPXC SPX Technologies | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $133.92
-1.6% | $126.00 ➝ $142.00 | Neutral ➝ Neutral | |
SQSP Squarespace | Reiterated by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.80
+2.5% | $40.00 ➝ $45.00 | Overweight ➝ Overweight | |
SQSP Squarespace | Target Raised by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.80
+2.5% | $35.00 ➝ $38.00 | Sector Perform ➝ Sector Perform | |
SQSP Squarespace | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.80
+2.5% | $37.00 ➝ $40.00 | Equal Weight ➝ Equal Weight | |
SRE Sempra | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $75.23
+1.7% | $79.00 ➝ $84.00 | Overweight ➝ Overweight | |
SRRK Scholar Rock | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.50
-1.3% | $30.00 | Buy ➝ Buy | |
STAA STAAR Surgical | Target Raised by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.02
-12.1% | $53.00 ➝ $55.00 | Buy ➝ Buy | |
STAA STAAR Surgical | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.02
-12.1% | | Hold | |
STAA STAAR Surgical | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.02
-12.1% | $33.00 ➝ $40.00 | Neutral ➝ Neutral | |
STAA STAAR Surgical | Target Lowered by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.02
-12.1% | $46.00 ➝ $43.00 | Hold ➝ Hold | |
STEM Stem | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1.36
+5.4% | $5.00 ➝ $2.50 | Buy ➝ Buy | |
STKS ONE Group Hospitality | Reiterated by | Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.63
-3.5% | $9.00 | Overweight ➝ Overweight | |
STRO Sutro Biopharma | Initiated by | Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.28
+0.7% | $12.00 | Buy | |
SYM Symbotic | Target Raised by | Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $48.36
+4.0% | $55.00 ➝ $60.00 | Buy ➝ Buy | |
TACT TransAct Technologies | Target Lowered by | Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.87
-1.3% | $9.00 ➝ $7.50 | Buy ➝ Buy | |
TBI TrueBlue | Target Lowered by | BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $10.54
-0.2% | $15.00 ➝ $13.00 | Outperform ➝ Outperform | |
TBLA Taboola.com | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.54
+0.2% | $6.00 | Buy ➝ Buy | |
TDG TransDigm Group | Target Raised by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,315.00
+0.4% | $1,300.00 ➝ $1,400.00 | Outperform ➝ Outperform | |
TDG TransDigm Group | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,315.00
+0.4% | $1,260.00 ➝ $1,390.00 | Equal Weight ➝ Equal Weight | |
TDG TransDigm Group | Target Raised by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,315.00
+0.4% | $1,300.00 ➝ $1,400.00 | Buy ➝ Buy | |
TDG TransDigm Group | Target Raised by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,315.00
+0.4% | $1,290.00 ➝ $1,357.00 | Outperform ➝ Outperform | |
TDG TransDigm Group | Target Raised by | Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,315.00
+0.4% | $1,100.00 ➝ $1,200.00 | Neutral ➝ Neutral | |
TDG TransDigm Group | Target Raised by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,315.00
+0.4% | $1,267.00 ➝ $1,425.00 | Buy ➝ Buy | |
TDG TransDigm Group | Target Raised by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $1,315.00
+0.4% | $1,302.00 ➝ $1,403.00 | Neutral ➝ Neutral | |
TFC Truist Financial | Target Raised by | Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.39
+0.7% | $45.00 ➝ $46.00 | Outperform ➝ Outperform | |
TFC Truist Financial | Target Raised by | HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.39
+0.7% | $40.00 ➝ $41.00 | Hold ➝ Hold | |
THS TreeHouse Foods | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.80
-2.0% | $39.00 ➝ $36.00 | Equal Weight ➝ Equal Weight | |
TMCI Treace Medical Concepts | Downgraded by | Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.17
-62.5% | $17.00 ➝ $7.00 | Buy ➝ Hold | |
TMCI Treace Medical Concepts | Downgraded by | BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.17
-62.5% | | Buy ➝ Neutral | |
TMCI Treace Medical Concepts | Downgraded by | JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.17
-62.5% | $15.00 ➝ $8.00 | Overweight ➝ Neutral | |
TMCI Treace Medical Concepts | Downgraded by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.17
-62.5% | $15.00 ➝ $6.00 | Buy ➝ Hold | |
TMCI Treace Medical Concepts | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.17
-62.5% | $17.00 ➝ $16.00 | Buy ➝ Buy | |
TMCI Treace Medical Concepts | Downgraded by | Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.17
-62.5% | $15.00 ➝ $5.50 | Overweight ➝ Equal Weight | |
TOST Toast | Target Raised by | Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.82
+13.0% | $25.00 ➝ $26.00 | Market Perform ➝ Market Perform | |
TOST Toast | Target Raised by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.82
+13.0% | $26.00 ➝ $30.00 | Buy ➝ Buy | |
TOST Toast | Target Raised by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.82
+13.0% | $23.00 ➝ $27.00 | Sector Perform ➝ Sector Perform | |
TOST Toast | Target Raised by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.82
+13.0% | $22.00 ➝ $28.00 | Buy ➝ Buy | |
TOST Toast | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $26.82
+13.0% | $17.00 ➝ $19.00 | Underweight ➝ Underweight | |
TPX Tempur Sealy International | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.08
+0.0% | $66.00 | Outperform ➝ Outperform | |
TRVI Trevi Therapeutics | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.64
-9.0% | $8.00 | Buy ➝ Buy | |
TWKS Thoughtworks | Target Raised by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.07
+1.7% | $5.00 ➝ $6.00 | Outperform ➝ Outperform | |
TWKS Thoughtworks | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.07
+1.7% | $6.00 | Outperform ➝ Outperform | |
TWKS Thoughtworks | Target Raised by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.07
+1.7% | $2.50 ➝ $3.25 | Neutral ➝ Neutral | |
TWLO Twilio | Target Lowered by | Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.62
-7.5% | $69.00 ➝ $63.00 | Neutral ➝ Neutral | |
TWLO Twilio | Target Lowered by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.62
-7.5% | $90.00 ➝ $85.00 | Buy ➝ Buy | |
TWLO Twilio | Target Lowered by | Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.62
-7.5% | $70.00 ➝ $68.00 | Market Perform ➝ Market Perform | |
TWLO Twilio | Target Raised by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.62
-7.5% | $78.00 ➝ $79.00 | Overweight ➝ Overweight | |
TWLO Twilio | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.62
-7.5% | $71.00 | Buy ➝ Buy | |
TWLO Twilio | Target Lowered by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $58.62
-7.5% | $70.00 ➝ $65.00 | Neutral ➝ Neutral | |
UBER Uber Technologies | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $66.40
-5.7% | $90.00 | Buy ➝ Buy | |
UL Unilever | Target Raised by | Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.69
+0.1% | $58.00 ➝ $60.00 | Buy ➝ Buy | |
UPST Upstart | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.11
-5.6% | | Hold | |
UPST Upstart | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.11
-5.6% | $10.00 | Underperform ➝ Underperform | |
VAC Marriott Vacations Worldwide | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $96.50
-2.7% | $102.00 ➝ $106.00 | Equal Weight ➝ Equal Weight | |
VALN Valneva | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.24
-3.5% | $26.00 | Buy ➝ Buy | |
VCYT Veracyte | Target Lowered by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.12
-4.3% | $33.00 ➝ $27.00 | Buy ➝ Buy | |
VECO Veeco Instruments | Target Raised by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.29
+4.8% | $43.00 ➝ $46.00 | Buy ➝ Buy | |
VECO Veeco Instruments | Target Raised by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.29
+4.8% | $33.00 ➝ $35.00 | Equal Weight ➝ Equal Weight | |
VIGL Vigil Neuroscience | Reiterated by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.78
+18.5% | $24.00 | Buy ➝ Buy | |
VIGL Vigil Neuroscience | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.78
+18.5% | $22.00 | Outperform ➝ Outperform | |
VNO Vornado Realty Trust | Target Lowered by | Compass Point
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.71
-2.1% | $28.00 ➝ $27.00 | Neutral ➝ Neutral | |
VPG Vishay Precision Group | Downgraded by | B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $31.31
-6.6% | $37.00 ➝ $36.00 | Buy ➝ Neutral | |
VSCO Victoria's Secret & Co. | Downgraded by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.03
+0.6% | $15.00 ➝ $14.00 | Equal Weight ➝ Underweight | |
VVX V2X | Target Raised by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.93
+0.1% | $52.00 ➝ $56.00 | Hold ➝ Hold | |
VVX V2X | Target Raised by | Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $49.93
+0.1% | $50.00 ➝ $55.00 | Outperform ➝ Outperform | |
WAL Western Alliance Bancorporation | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $62.98
+1.3% | $70.00 | Outperform ➝ Outperform | |
WAT Waters | Target Raised by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $323.80
-0.7% | $330.00 ➝ $332.00 | Hold ➝ Hold | |
WAT Waters | Target Lowered by | Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $323.80
-0.7% | $319.00 ➝ $312.00 | Neutral ➝ Neutral | |
WAT Waters | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $323.80
-0.7% | $300.00 ➝ $295.00 | Underweight ➝ Underweight | |
WAT Waters | Target Raised by | TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $323.80
-0.7% | $350.00 ➝ $358.00 | Hold ➝ Hold | |
WELL Welltower | Target Raised by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $98.40
+1.0% | $98.00 ➝ $105.00 | Buy ➝ Buy | |
WMB Williams Companies | Target Raised by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.32
+0.5% | $40.00 ➝ $43.00 | Buy ➝ Buy | |
WMB Williams Companies | Target Raised by | CIBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.32
+0.5% | $38.00 ➝ $39.00 | Neutral ➝ Neutral | |
WMS Advanced Drainage Systems | Initiated by | Northcoast Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $168.20
+0.0% | $190.00 | Buy | |
WOW WideOpenWest | Downgraded by | Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.65
+0.2% | | Outperform ➝ Market Perform | |
WWW Wolverine World Wide | Reiterated by | Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.74
+11.6% | $10.00 ➝ $10.00 | Market Perform ➝ Market Perform | |
WYNN Wynn Resorts | Target Raised by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $95.75
-1.5% | $125.00 ➝ $128.00 | Overweight ➝ Overweight | |
WYNN Wynn Resorts | Target Raised by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $95.75
-1.5% | $135.00 ➝ $138.00 | Buy ➝ Buy | |
WYNN Wynn Resorts | Target Raised by | Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $95.75
-1.5% | $132.00 ➝ $138.00 | Buy ➝ Buy | |
YOU Clear Secure | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.18
-5.0% | $40.00 | Buy ➝ Buy | |
YOU Clear Secure | Reiterated by | Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.18
-5.0% | $21.00 | Neutral ➝ Neutral | |
ZI ZoomInfo Technologies | Target Lowered by | Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14
-24.2% | $28.00 ➝ $21.00 | Overweight ➝ Overweight | |
ZI ZoomInfo Technologies | Reiterated by | Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14
-24.2% | $25.00 | Buy ➝ Buy | |
ZI ZoomInfo Technologies | Target Lowered by | Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14
-24.2% | $22.00 ➝ $20.00 | Buy ➝ Buy | |
ZI ZoomInfo Technologies | Target Lowered by | Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14
-24.2% | $19.00 ➝ $15.00 | Equal Weight ➝ Equal Weight | |
ZI ZoomInfo Technologies | Target Lowered by | KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14
-24.2% | $20.00 ➝ $18.00 | Overweight ➝ Overweight | |
ZI ZoomInfo Technologies | Target Lowered by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14
-24.2% | $24.00 ➝ $20.00 | Buy ➝ Buy | |
ZI ZoomInfo Technologies | Target Lowered by | UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14
-24.2% | $19.00 ➝ $16.00 | Neutral ➝ Neutral | |
ZI ZoomInfo Technologies | Downgraded by | The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14
-24.2% | $19.50 ➝ $12.00 | Neutral ➝ Sell | |
ZI ZoomInfo Technologies | Downgraded by | Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14
-24.2% | $24.00 ➝ $15.00 | Overweight ➝ Neutral | |
ZI ZoomInfo Technologies | Downgraded by | Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.14
-24.2% | $23.00 ➝ $14.00 | Buy ➝ Neutral | |
ZNTL Zentalis Pharmaceuticals | Target Lowered by | Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.43
+1.0% | $36.00 ➝ $32.00 | Buy ➝ Buy | |
ZNTL Zentalis Pharmaceuticals | Target Lowered by | HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $12.43
+1.0% | $46.00 ➝ $40.00 | Buy ➝ Buy | |
ZTS Zoetis | Target Lowered by | HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $164.92
-2.1% | $230.00 ➝ $225.00 | Buy ➝ Buy | |
